Asthma Drug trial Halted -Health Risk Are Suspected Mon, 17 Mar 2003 A spate of recent articles have shown that pharmaceutical companies suppress the publication of negative findings about their products. However, that is not the only way these companies keep physicians and patients uninformed about adverse drug effects. Another…
Cost and Consequence: drug “cocktails” deplete Medicaid_Globe Tue, 24 Jun 2003 The escalating cost of healthcare is in large measure due tothe spiraling expenditure on drugs–many of which are misprescribed.The Boston Globe reports about one Medicaid patient who is prescribed18 medications at a cost of roughly $16,000 a year–“all at…
FDA Scientist Won’t Present New Pain Drug Data – FDA to Create Independent Drug Safety Board Tue, 15 Feb 2005 A culture of intimidation prevents FDA safety officers from disclosing important safety information about widely marketed drugs. Reuters reports: “Criticism of how the FDA monitors the after-market safety of drugs…
Public Comments: Dr. William J. Bicknell, Professor of International Health, Boston University Dear Dr. Ball: I am submitting these comments in reference to the announcement published in the Federal Register, Vol. 67, No. 211, Thursday, October 31, 2002 regarding the Solicitation of Public Review and Comment on Research Protocol: A…
Selling Sickness: Pharma Industry Turning Us All Into Patients Mon, 12 Sep 2005 Related Link: Selling Sickness Prologue Selling Sickness: How the World’s Pharmaceutical Companies Are Turning Us All Into Patients, by Ray Moynihan, an international health journalist, and Alan Cassels, a pharmaceutical policy researcher, is likely to become a…
Date: Thu, 30 May 2002 14:14:47 -0400 From: Vera Subject: Bitter Medicine: Pills, Profit & the Public Health_ABC News ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI On May 17 The Wall Street Journal reported (in a front page article) that drug…
$95 billion a year spent on medical research in US – JAMA Fri, 23 Sep 2005 A special issue of the Journal of the American Medical Association, JAMA, focuses on medical research spending and findings. A study that examined US spending for medical research—$95 billion approaching $100 billion–57% is spent…
September 25, 2002 NIH suspended ARDS Lung experiment in Aug / AHRP filed complaint re: ARDS in July FYI On July 29, 2002 The Alliance for Human Research Protection (AHRP) filed a complaint with the federal Office of Human Research Protections (OHRP), expressing ethical and methodological concerns about an acute…
For the Sake of Public Safety FDA & NIH Must Be Detatched from Drug Industry Tue, 21 Dec 2004 Daily front page reports about lethal drug effects leave no doubt that we are in the midst of a major health safety and credibility crisis, largely due to a drug development…
SSRI Defects: Infants Suffer Drug Withdrawal / Adults risk GI bleeding Wed, 18 May 2005 The Associated Press reports that new research confirms that: “Babies born to women taking antidepressants in the last three months of pregnancy were three times more likely to develop drug-related symptoms than those born to…
Doctor Tells Pfizer Sales Rep who promoted Celebrex: “Have You No Shame?” Sun, 26 Dec 2004 An opinion piece by Dr. Marc Siegel, an internist and professor at New York University School of Medicine, expresses the anger and dismay many physicians in the US feel about having been misled by…
Pfizer PainKiller Bextra withdrawn from market, New Boxed Warnings for Celebrex Thu, 07 Apr 2005 Pfizer’s withdrawal of the COX-2 pain reliever, Bextra, from the market because of potentially lethal side effects, including increased risk of cardiovascular malfunction and severe rash, validates Dr. David Graham’s analysis. This FDA medical expert…
